223 related articles for article (PubMed ID: 33040466)
1. Type I interferon signaling limits viral vector priming of CD8
Riding RL; Richmond JM; Fukuda K; Harris JE
Pigment Cell Melanoma Res; 2021 Jul; 34(4):683-695. PubMed ID: 33040466
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma.
Byrne KT; Zhang P; Steinberg SM; Turk MJ
J Immunol; 2014 Feb; 192(4):1433-9. PubMed ID: 24403535
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
Overwijk WW; Lee DS; Surman DR; Irvine KR; Touloukian CE; Chan CC; Carroll MW; Moss B; Rosenberg SA; Restifo NP
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2982-7. PubMed ID: 10077623
[TBL] [Abstract][Full Text] [Related]
4. Effector and stem-like memory cell fates are imprinted in distinct lymph node niches directed by CXCR3 ligands.
Duckworth BC; Lafouresse F; Wimmer VC; Broomfield BJ; Dalit L; Alexandre YO; Sheikh AA; Qin RZ; Alvarado C; Mielke LA; Pellegrini M; Mueller SN; Boudier T; Rogers KL; Groom JR
Nat Immunol; 2021 Apr; 22(4):434-448. PubMed ID: 33649580
[TBL] [Abstract][Full Text] [Related]
5. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.
Rashighi M; Agarwal P; Richmond JM; Harris TH; Dresser K; Su MW; Zhou Y; Deng A; Hunter CA; Luster AD; Harris JE
Sci Transl Med; 2014 Feb; 6(223):223ra23. PubMed ID: 24523323
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
[TBL] [Abstract][Full Text] [Related]
7. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
[TBL] [Abstract][Full Text] [Related]
8. Targeting the PD-1/PD-L1 Axis in Human Vitiligo.
Willemsen M; Melief CJM; Bekkenk MW; Luiten RM
Front Immunol; 2020; 11():579022. PubMed ID: 33240267
[TBL] [Abstract][Full Text] [Related]
9. Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.
Bronte V; Apolloni E; Ronca R; Zamboni P; Overwijk WW; Surman DR; Restifo NP; Zanovello P
Cancer Res; 2000 Jan; 60(2):253-8. PubMed ID: 10667570
[TBL] [Abstract][Full Text] [Related]
10. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
[TBL] [Abstract][Full Text] [Related]
11. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
Volz A; Langenmayer M; Jany S; Kalinke U; Sutter G
J Virol; 2014 Sep; 88(18):10946-57. PubMed ID: 25008931
[TBL] [Abstract][Full Text] [Related]
12. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma.
Byrne KT; Côté AL; Zhang P; Steinberg SM; Guo Y; Allie R; Zhang W; Ernstoff MS; Usherwood EJ; Turk MJ
J Clin Invest; 2011 May; 121(5):1797-809. PubMed ID: 21540555
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligo.
Willemsen M; Krebbers G; Tjin EPM; Willemsen KJ; Louis A; Konijn VAL; Narayan VS; Post NF; Bakker WJ; Melief CJM; Bekkenk MW; Luiten RM
Exp Dermatol; 2022 Apr; 31(4):556-566. PubMed ID: 34758170
[TBL] [Abstract][Full Text] [Related]
15. Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.
Xiao H; Peng Y; Hong Y; Liu Y; Guo ZS; Bartlett DL; Fu N; He Y
J Immunol; 2011 Aug; 187(4):1788-96. PubMed ID: 21746967
[TBL] [Abstract][Full Text] [Related]
16. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
[TBL] [Abstract][Full Text] [Related]
18. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
[TBL] [Abstract][Full Text] [Related]
19. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
20. Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression.
Hwang HS; Cherukula K; Bang YJ; Vijayan V; Moon MJ; Thiruppathi J; Puth S; Jeong YY; Park IK; Lee SE; Rhee JH
Cells; 2020 Nov; 9(11):. PubMed ID: 33171765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
